Gate2Brain obtains FDA Orphan Drug Designation for G2B-002

, ,
US FDA grants Orphan Drug Designation for G2B-002 in 2025, underscoring U.S. regulatory support for…

Validation of Gate2Brain Technology in the Transport of Antibodies to the Brain Opens the Avenue of the Next Generation of CNS Therapeutics with Improved Delivery to the Brain

,
Image: Marina Plaza Press release New research highlights how advanced peptide shuttles—the…

Clàudia Resa, G2B’s Doctoral Industrial PhD student : “I am proud have developed a new drug delivery system against childhood brain cancer”

,
Research in pediatric oncology: Clàudia Resa is the industrial doctoral student in the project between…

Imitating nature to improve health

, ,
Regenerating skin or delivering medication to specific areas of our body is now possible thanks to the…

Science or science fiction? Research that reads like something out of a book

Long before the first robot hoover existed, the laws that would shape its relationship with humans had…

Gate2brain Achieves Emerging Company Certification from Enisa

,
Gate2brain S.L. has proudly received the Emerging Company Certification issued by the Ministry of Industry…

Bioengineering the Future of Drug Delivery workshop – Porto

,
Our CEO, Meritxell Teixido, and Chemist Research Scientist Marina Plaza Garrido recently participated…

Gate2Brain at the 2nd Peptide-Based Therapeutics Summit | Boston

,
📅 April 1-3, 2025 📍 Boston, USA We’re excited to share that Gate2Brain will be participating…

Keystone Symposia on Drug Delivery to the Brain: Emerging Modalities

,
Breaking Barriers and Sharing Innovation with Leaders in Brain Drug Delivery At Gate2Brain, we are…

Gate2Brain Named Best Startup of January 2025 at Keiretsu Forum Barcelona

,
Gate2Brain has been honored with the Best Startup Award at the latest Keiretsu Forum in EADA Business…

International Day of Women & Girls in Science

Celebrating Women and Girls in Science! At Gate2Brain, we believe that curiosity, passion, and determination…

Meet Gate2Brain 2024 Interns

,
Last year, Gate2Brain had the honor of welcoming three talented interns from different corners of the…

Meet the Advisory Board – Andrés G. Fernández

, ,
We are continuing to introduce the remarkable individuals who make up Gate2Brain’s external advisory…

Navigating the ecosystem of pharma companies and investors at JP Morgan-RESI

, ,
Navigating the vibrant ecosystem of pharma companies and investors during J.P. Morgan San Francisco and…

Companies to Watch 2025

,
By Dennis Ford, Founder & CEO, Life Science Nation (LSN) Life Science Nation (LSN) has established…
Gate2Brain

Gate2Brain is a biotech company focused on the development of therapeutics that efficiently cross biological barriers such as the blood-brain barrier. We use a radically innovative peptide-based patented technology.

Where to find us

Barcelona Scientific Park
Baldiri Reixac, 4-8, Torre I
08028 Barcelona, Spain
info@gate2brain.com

Social